Quantcast
Channel: cafepharma - chronic kidney disease
Browsing all 27 articles
Browse latest View live

News

Impax Laboratories Confirms Patent Challenge Relating to RENVELA®, 2.4 g and 0.8 g (For Suspension) Yahoo/BusinessWire

View Article



News

Private Biotechs Take Different Avenues to Rake in Cash Seeking Alpha

View Article

News

VYTORIN(R) (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease in a New 9,000-Patient Investigational Study MarketWatch

View Article

Proteon Therapeutics advances drug candidate, sale to Novartis

Proteon Therapeutics advances drug candidate, sale to Novartis Bizjournals.com

View Article

Affymax, Takeda seek approval of peginesatide in dialysis patients with...

Affymax, Takeda seek approval of peginesatide in dialysis patients with chronic kidney disease Yahoo/AP

View Article


Abbott's Bardoxolone in Phase III

Abbott's Bardoxolone in Phase III Yahoo/Zacks

View Article

Amgen Announces Modifications to U.S. Prescribing Information for Use of...

Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease Yahoo/PR NewsWire

View Article

FDA recommends lower doses of anemia drugs

FDA recommends lower doses of anemia drugs Yahoo/AP

View Article


Abbott Reveals Positive Results From Phase-2 Trial Of Kidney Drug

Abbott Reveals Positive Results From Phase-2 Trial Of Kidney Drug RTT News

View Article


FDA sets date to review Affymax anemia drug

FDA sets date to review Affymax anemia drug Yahoo/AP

View Article

Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies...

Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011 Yahoo/BusinessWire

View Article

Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug

Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug Bloomberg

View Article

US FDA panel gives positive opinion to Affymax's anaemia drug peginesatide

US FDA panel gives positive opinion to Affymax's anaemia drug peginesatide Pharmabiz

View Article


Dynavax reports final Phase 3 data for HEPLISAV

Dynavax reports final Phase 3 data for HEPLISAV Yahoo/Fly on the Wall

View Article

Affymax Poised To Take On Amgen?

Affymax Poised To Take On Amgen? Seeking Alpha

View Article


AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of...

AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease Enhanced...

View Article

Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell...

Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical Seeking Alpha

View Article


Keryx Patents Seen Overcoming Generic Competition

Keryx Patents Seen Overcoming Generic Competition Investors.com

View Article

Takeda Withdraws MAA for Omontys in Europe

Takeda Withdraws MAA for Omontys in Europe NASDAQ

View Article

Rockwell Medical: Undervalued After CRUISE-1 Results

Rockwell Medical: Undervalued After CRUISE-1 Results Seeking Alpha

View Article
Browsing all 27 articles
Browse latest View live




Latest Images